Neurostimulation Devices Market by Device Type (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, and Others) Application (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026
The global neurostimulation devices market was valued at $4,387.5 million in 2018 and is projected to reach $11,257.4 million by 2026, registering a CAGR of 12.5% from 2019 to 2026. Neurostimulation is an electrical process of stimulating, inhibiting, modifying, regulating, and altering the activity in the central, autonomous, or peripheral nervous system in the human body. Neurostimulation devices send electrical impulse near to the spine region wherein these signals block the pain signals from reaching the brain. These devices deliver electrical stimulation to the patient’s brain, spinal cord, and peripheral nervous system. Neurostimulation devices are particularly used for the treatment of neurological disorders such as epilepsy, chronic pain, Parkinson’s disease, depression, and other diseases. Advancements in the neurological technologies is delivering relief to the patients affected by psychiatric and neurological disorders.
According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 60–70% are Alzheimer’s and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinson’s disease is 4.5–19 per 100,000 population every year.
Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.
The neurostimulation devices market is classified on the basis of device type, application, and region. Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. On the basis of application, the market is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players operating in the neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.
KEY BENEFITS FOR STAKEHOLDERS
By Device Type
According to the data published by WHO, there are around 50 million cases of dementia across the globe among which 60–70% are Alzheimer’s and 10 million are added every year. Dementia is the fifth leading cause of death worldwide. Furthermore, the incidence rate for Parkinson’s disease is 4.5–19 per 100,000 population every year.
Rise in prevalence of lifestyle diseases such as depression and chronic pain, increase in number of neurological disorders, and investment for neurological R&D are some of the factors that drive the growth of the global neurostimulation devices market. Moreover, rise in demand for minimal invasive surgery, adoption of technologically advanced products, and surge in aging population also propel the growth of the market as they are more susceptible to neurological disorders, such as Epilepsy, Parkinson’s disease, Alzheimer’s disease, and chronic pain. The major barriers for the growth of the neurostimulation devices market are side effects such as allergic reaction and tingling or prickling of the skin due to implantation of neurostimulation device into the body and increase in device cost. However, the availability of other treatment options such as drug therapies and surgeries restrict the growth of the market.
The neurostimulation devices market is classified on the basis of device type, application, and region. Based on device type, the neurostimulation devices market is divided into spinal cord stimulators, deep brain stimulators, sacral nerve stimulators, vagus nerve stimulators, and others. On the basis of application, the market is classified into pain management, hearing loss, urinary incontinence, Parkinson's disease, epilepsy, and others. Region wise, it is studied across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major players operating in the neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro corporation, Neuronetics Inc., NeuroSigma, Inc., and Synapse Biomedical Inc.
KEY BENEFITS FOR STAKEHOLDERS
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- The key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
By Device Type
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Others
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- Spain
- Italy
- UK
- Rest of Europe
- Asia-Pacific
- Japan
- India
- China
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Abbott Laboratories
- Aleva neurotherapeutics SA
- Boston scientific corporation
- ElectroCore Inc.
- EndoStim Inc.
- Medtronic plc
- NeuroPace Inc.
- Nevro corporation
- Neuronetics Inc.
- NeuroSigma, Inc.
- Synapse Biomedical Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in prevalence of neurological disorders
3.3.1.2.Increase in investments in R&D for neurological disorders
3.3.2.Restraints
3.3.2.1.Adverse effects and risks associated with neurostimulation devices
3.3.3.Opportunities
3.3.3.1.Use of neurostimulators for new indications
CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Spinal Cord Stimulators
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Deep Brain Stimulators
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Sacral Nerve Stimulators
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Vagus Nerve Stimulators
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Pain Management
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Hearing Loss
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Urinary Incontinence
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Parkinson's Disease
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Epilepsy
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by device type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by device type
6.2.4.2.U.S. market size and forecast, by application
6.2.4.3.Canada market size and forecast, by device type
6.2.4.4.Canada market size and forecast, by application
6.2.4.5.Mexico market size and forecast, by device type
6.2.4.6.Mexico market size and forecast, by application
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by device type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country
6.3.4.1.Germany market size and forecast, by device type
6.3.4.2.Germany market size and forecast, by application
6.3.4.3.France market size and forecast, by device type
6.3.4.4.France market size and forecast, by application
6.3.4.5.UK market size and forecast, by device type
6.3.4.6.UK market size and forecast, by application
6.3.4.7.Italy market size and forecast, by device type
6.3.4.8.Italy market size and forecast, by application
6.3.4.10.Rest of Europe market size and forecast, by device type
6.3.4.11.Rest of Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by device type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.4.1.Japan market size and forecast, by device type
6.4.4.2.Japan market size and forecast, by application
6.4.4.3.China market size and forecast, by device type
6.4.4.4.China market size and forecast, by application
6.4.4.5.India market size and forecast, by device type
6.4.4.6.India market size and forecast, by application
6.4.4.7.Australia market size and forecast, by device type
6.4.4.8.Australia market size and forecast, by application
6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by device type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by device type
6.5.4.2.Brazil market size and forecast, by application
6.5.4.3.Saudi market size and forecast, by device type
6.5.4.4.Saudi market size and forecast, by application
6.5.4.5.South Africa market size and forecast, by device type
6.5.4.6.South Africa market size and forecast, by application
6.5.4.7.Rest of LAMEA market size and forecast, by device type
6.5.4.8.Rest of LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.Abbott Laboratories
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.Aleva Neurotherapeutics SA
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments
7.3.Boston Scientific Corporation
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.ElectroCore Inc.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.EndoStim Inc.
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.6.Medtronic plc
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
Source: Corporate Publications and AMR Analysis
7.7.NeuroPace Inc.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.Nevro Corporation
7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performances
7.8.5.Key strategic moves and developments
7.9.Neuronetics Inc.
7.9.1.Company overview
7.9.2.Neuronetics: Company Snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.NeuroSigma Inc.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
7.11.Synapse Biomedical Inc.
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Key strategic moves and developments
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Rise in prevalence of neurological disorders
3.3.1.2.Increase in investments in R&D for neurological disorders
3.3.2.Restraints
3.3.2.1.Adverse effects and risks associated with neurostimulation devices
3.3.3.Opportunities
3.3.3.1.Use of neurostimulators for new indications
CHAPTER 4:NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Spinal Cord Stimulators
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Deep Brain Stimulators
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Sacral Nerve Stimulators
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
4.5.Vagus Nerve Stimulators
4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country
4.6.Others
4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast, by region
4.6.3.Market analysis, by country
CHAPTER 5:NEUROSTIMULATION DEVICES MARKET, BY APPLICATION
5.1.Overview
5.1.1.Market size and forecast
5.2.Pain Management
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Hearing Loss
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.4.Urinary Incontinence
5.4.1.Market size and forecast, by region
5.4.2.Market analysis, by country
5.5.Parkinson's Disease
5.5.1.Market size and forecast, by region
5.5.2.Market analysis, by country
5.6.Epilepsy
5.6.1.Market size and forecast, by region
5.6.2.Market analysis, by country
5.7.Others
5.7.1.Market size and forecast, by region
5.7.2.Market analysis, by country
CHAPTER 6:GLOBAL NEUROSTIMULATION DEVICES MARKET, BY REGION
6.1.Overview
6.1.1.Market size and forecast
6.2.North America
6.2.1.Key market trends and opportunities
6.2.2.Market size and forecast, by device type
6.2.3.Market size and forecast, by application
6.2.4.Market size and forecast, by country
6.2.4.1.U.S. market size and forecast, by device type
6.2.4.2.U.S. market size and forecast, by application
6.2.4.3.Canada market size and forecast, by device type
6.2.4.4.Canada market size and forecast, by application
6.2.4.5.Mexico market size and forecast, by device type
6.2.4.6.Mexico market size and forecast, by application
6.3.Europe
6.3.1.Key market trends and opportunities
6.3.2.Market size and forecast, by device type
6.3.3.Market size and forecast, by application
6.3.4.Market size and forecast, by country
6.3.4.1.Germany market size and forecast, by device type
6.3.4.2.Germany market size and forecast, by application
6.3.4.3.France market size and forecast, by device type
6.3.4.4.France market size and forecast, by application
6.3.4.5.UK market size and forecast, by device type
6.3.4.6.UK market size and forecast, by application
6.3.4.7.Italy market size and forecast, by device type
6.3.4.8.Italy market size and forecast, by application
6.3.4.10.Rest of Europe market size and forecast, by device type
6.3.4.11.Rest of Europe market size and forecast, by application
6.4.Asia-Pacific
6.4.1.Key market trends and opportunities
6.4.2.Market size and forecast, by device type
6.4.3.Market size and forecast, by application
6.4.4.Market size and forecast, by country
6.4.4.1.Japan market size and forecast, by device type
6.4.4.2.Japan market size and forecast, by application
6.4.4.3.China market size and forecast, by device type
6.4.4.4.China market size and forecast, by application
6.4.4.5.India market size and forecast, by device type
6.4.4.6.India market size and forecast, by application
6.4.4.7.Australia market size and forecast, by device type
6.4.4.8.Australia market size and forecast, by application
6.4.4.9.Rest of Asia-Pacific market size and forecast, by device type
6.4.4.10.Rest of Asia-Pacific market size and forecast, by application
6.5.LAMEA
6.5.1.Key market trends and opportunities
6.5.2.Market size and forecast, by device type
6.5.3.Market size and forecast, by application
6.5.4.Market size and forecast, by country
6.5.4.1.Brazil market size and forecast, by device type
6.5.4.2.Brazil market size and forecast, by application
6.5.4.3.Saudi market size and forecast, by device type
6.5.4.4.Saudi market size and forecast, by application
6.5.4.5.South Africa market size and forecast, by device type
6.5.4.6.South Africa market size and forecast, by application
6.5.4.7.Rest of LAMEA market size and forecast, by device type
6.5.4.8.Rest of LAMEA market size and forecast, by application
CHAPTER 7:COMPANY PROFILES
7.1.Abbott Laboratories
7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio
7.1.5.Business performance
7.1.6.Key strategic moves and developments
7.2.Aleva Neurotherapeutics SA
7.2.1.Company overview
7.2.2.Company snapshot
7.2.3.Operating business segments
7.2.4.Product portfolio
7.2.5.Key strategic moves and developments
7.3.Boston Scientific Corporation
7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Operating business segments
7.3.4.Product portfolio
7.3.5.Business performance
7.3.6.Key strategic moves and developments
7.4.ElectroCore Inc.
7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio
7.4.5.Business performance
7.5.EndoStim Inc.
7.5.1.Company overview
7.5.2.Operating business segments
7.5.3.Product portfolio
7.6.Medtronic plc
7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio
7.6.5.Business performance
Source: Corporate Publications and AMR Analysis
7.7.NeuroPace Inc.
7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Key strategic moves and developments
7.8.Nevro Corporation
7.8.1.Company overview
7.8.2.Operating business segment
7.8.3.Product portfolio
7.8.4.Business performances
7.8.5.Key strategic moves and developments
7.9.Neuronetics Inc.
7.9.1.Company overview
7.9.2.Neuronetics: Company Snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance
7.9.6.Key strategic moves and developments
7.10.NeuroSigma Inc.
7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Key strategic moves and developments
7.11.Synapse Biomedical Inc.
7.11.1.Company overview
7.11.2.Company snapshot
7.11.3.Operating business segments
7.11.4.Product portfolio
7.11.5.Key strategic moves and developments
LIST OF TABLES
TABLE 01.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 02.NEUROSTIMULATION DEVICES MARKET, FOR SPINAL CORD STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 03.NEUROSTIMULATION DEVICES MARKET, FOR DEEP BRAIN STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 04.NEUROSTIMULATION DEVICES MARKET, FOR SACRAL NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 05.NEUROSTIMULATION DEVICES MARKET, FOR VAGUS NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 06.NEUROSTIMULATION DEVICES MARKET, FOR OTHERS BY REGION, 2018–2026 ($MILLION)
TABLE 07.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08.NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 09.NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY REGION, 2018–2026 ($MILLION)
TABLE 10.NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY REGION, 2018–2026 ($MILLION)
TABLE 11.NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 12.NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)
TABLE 13.NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 15.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 16.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 17.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 18.U.S. NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 19.U.S. NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 20.CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 21.CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 22.MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 23.MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 24.EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 25.EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 26.EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 27.GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 28.GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29.FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 30.FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 31.UK NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 32.UK NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 33.ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 34.ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 35.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 36.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 37.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 38.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 39.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 40.JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 41.JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42.CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 43.CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 44.INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 45.INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 46.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 47.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 50.LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 51.LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 52.LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 53.BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 54.BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 55.SAUDI NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 56.SAUDI NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 57.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 58.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 59.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 60.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 61.ABBOTT: COMPANY SNAPSHOT
TABLE 62.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 63.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 64.Aleva neurotherapeutics: company Snapshot
TABLE 65.ALEVA NEUROTHERAPEUTICS: OPERATING SEGMENT
TABLE 66.ALEVA NEUROTHERAPEUTICS: PRODUCT PORTFOLIO
TABLE 68.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 69.BOSTON: PRODUCT PORTFOLIO
TABLE 70.ELECTROCORE INC: COMPANY SNAPSHOT
TABLE 71.ELCTROCORE: OPERATING SEGMENTS
TABLE 72.ELECTROCORE INC: PRODUCT PORTFOLIO
TABLE 73.ENDOSTIM INC: OPERATING SEGMENT
TABLE 74.ENDOSTIM INC: PRODUCT PORTFOLIO
TABLE 75.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 76.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 77.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 78.NEUROPACE INC.: COMPANY SNAPSHOT
TABLE 79.NEUROPACE INC.: OPERATING SEGMENTS
TABLE 80.NEUROPACE INC.: PRODUCT PORTFOLIO
TABLE 81.NEVRO CORPORATION.: OPERATING SEGMENTS
TABLE 82.NEVRO CORPORATION.: PRODUCT PORTFOLIO
TABLE 83.NEURONETICS: OPERATING SEGMENT
TABLE 84.NEURONETICS : PRODUCT PORTFOLIO
TABLE 85.NEUROSIGMA INC: COMPANY SNAPSHOT
TABLE 86.NEUROSIGMA INC COMPANY: PRODUCT SEGMENT
TABLE 87.NEUROSIGMA INC: PRODUCT PORTFOLIO
TABLE 88.SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT
TABLE 89.SYNAPSE BIOMEDICAL: OPERATING SEGMENT
TABLE 90.SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO
TABLE 01.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY DEVICE TYPE, 2018–2026 ($MILLION)
TABLE 02.NEUROSTIMULATION DEVICES MARKET, FOR SPINAL CORD STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 03.NEUROSTIMULATION DEVICES MARKET, FOR DEEP BRAIN STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 04.NEUROSTIMULATION DEVICES MARKET, FOR SACRAL NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 05.NEUROSTIMULATION DEVICES MARKET, FOR VAGUS NERVE STIMULATORS BY REGION, 2018–2026 ($MILLION)
TABLE 06.NEUROSTIMULATION DEVICES MARKET, FOR OTHERS BY REGION, 2018–2026 ($MILLION)
TABLE 07.GLOBAL NEUROSTIMULATION DEVICES MARKET, BY APPLICATION, 2018–2026 ($MILLION)
TABLE 08.NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT, BY REGION, 2018–2026 ($MILLION)
TABLE 09.NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY REGION, 2018–2026 ($MILLION)
TABLE 10.NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY REGION, 2018–2026 ($MILLION)
TABLE 11.NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY REGION, 2018–2026 ($MILLION)
TABLE 12.NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY REGION, 2018–2026 ($MILLION)
TABLE 13.NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY REGION, 2018–2026 ($MILLION)
TABLE 14.GLOBAL NEUROSTIMULATION DEVICES MARKET BY REGION, 2018-2026, ($MILLION)
TABLE 15.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 16.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 17.NORTH AMERICA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 18.U.S. NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 19.U.S. NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 20.CANADA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 21.CANADA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 22.MEXICO NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 23.MEXICO NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 24.EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 25.EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 26.EUROPE NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 27.GERMANY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 28.GERMANY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 29.FRANCE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 30.FRANCE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 31.UK NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 32.UK NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 33.ITALY NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 34.ITALY NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 35.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 36.REST OF EUROPE NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 37.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 38.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 39.ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 40.JAPAN NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 41.JAPAN NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 42.CHINA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 43.CHINA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 44.INDIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 45.INDIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 46.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 47.AUSTRALIA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 48.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 49.REST OF ASIA-PACIFIC NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 50.LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 51.LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 52.LAMEA NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2018-2026, ($MILLION)
TABLE 53.BRAZIL NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 54.BRAZIL NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 55.SAUDI NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 56.SAUDI NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 57.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 58.SOUTH AFRICA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 59.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY DEVICE TYPE, 2018-2026, ($MILLION)
TABLE 60.REST OF LAMEA NEUROSTIMULATION DEVICES MARKET BY APPLICATION, 2018-2026, ($MILLION)
TABLE 61.ABBOTT: COMPANY SNAPSHOT
TABLE 62.ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 63.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 64.Aleva neurotherapeutics: company Snapshot
TABLE 65.ALEVA NEUROTHERAPEUTICS: OPERATING SEGMENT
TABLE 66.ALEVA NEUROTHERAPEUTICS: PRODUCT PORTFOLIO
TABLE 68.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
TABLE 69.BOSTON: PRODUCT PORTFOLIO
TABLE 70.ELECTROCORE INC: COMPANY SNAPSHOT
TABLE 71.ELCTROCORE: OPERATING SEGMENTS
TABLE 72.ELECTROCORE INC: PRODUCT PORTFOLIO
TABLE 73.ENDOSTIM INC: OPERATING SEGMENT
TABLE 74.ENDOSTIM INC: PRODUCT PORTFOLIO
TABLE 75.MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 76.MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 77.MEDTRONIC: PRODUCT PORTFOLIO
TABLE 78.NEUROPACE INC.: COMPANY SNAPSHOT
TABLE 79.NEUROPACE INC.: OPERATING SEGMENTS
TABLE 80.NEUROPACE INC.: PRODUCT PORTFOLIO
TABLE 81.NEVRO CORPORATION.: OPERATING SEGMENTS
TABLE 82.NEVRO CORPORATION.: PRODUCT PORTFOLIO
TABLE 83.NEURONETICS: OPERATING SEGMENT
TABLE 84.NEURONETICS : PRODUCT PORTFOLIO
TABLE 85.NEUROSIGMA INC: COMPANY SNAPSHOT
TABLE 86.NEUROSIGMA INC COMPANY: PRODUCT SEGMENT
TABLE 87.NEUROSIGMA INC: PRODUCT PORTFOLIO
TABLE 88.SYNAPSE BIOMEDICAL: COMPANY SNAPSHOT
TABLE 89.SYNAPSE BIOMEDICAL: OPERATING SEGMENT
TABLE 90.SYNAPSE BIOMEDICAL: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.NEUROSTIMULATION DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 06.TOP IMPACTING FACTORS
FIGURE 07.NEUROSTIMULATION DEVICES, FOR SPINAL CORD STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.NEUROSTIMULATION DEVICES, FOR DEEP BRAIN STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.NEUROSTIMULATION DEVICES, FOR SACRAL NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.NEUROSTIMULATION DEVICES, FOR VAGUS NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.NEUROSTIMULATION DEVICES, FOR OTHERS BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18.ABBOTT LABORATORIES: NET SALES, 2016–2018 ($MILLION)
FIGURE 19.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 20.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018(%)
FIGURE 21.BOSTON: NET SALES, 2016–2018 ($MILLION)
FIGURE 22.BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 23.BOSTON: REVENUE SHARE BY REGION, BY 2018%
FIGURE 24.ELECTROCORE.: NET SALES, 2016–2018 ($MILLION)
FIGURE 25.ELECTROCORE INC.: REVENUE SHARE BY REGION,2018 %
FIGURE 26.MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 27.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 29.NEVRO CORPORATION.: NET SALES, 2016–2018 ($MILLION)
FIGURE 30.NEVRO CORPORATION.: REVENUE SHARE BY REGION,2018 %
FIGURE 31.NEURONETICS: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.NEURONETICS: REVENUE SHARE BY REGION, 2018(%)
FIGURE 01.NEUROSTIMULATION DEVICES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2019*
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2019* (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2019*
FIGURE 06.TOP IMPACTING FACTORS
FIGURE 07.NEUROSTIMULATION DEVICES, FOR SPINAL CORD STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 08.NEUROSTIMULATION DEVICES, FOR DEEP BRAIN STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 09.NEUROSTIMULATION DEVICES, FOR SACRAL NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 10.NEUROSTIMULATION DEVICES, FOR VAGUS NERVE STIMULATORS BY COUNTRY, 2018 & 2026 (%)
FIGURE 11.NEUROSTIMULATION DEVICES, FOR OTHERS BY COUNTRY, 2018 & 2026 (%)
FIGURE 12.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET, FOR PAIN MANAGEMENT BY COUNTRY, 2018 & 2026 (%)
FIGURE 13.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR HEARING LOSS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 14.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR URINARY INCONTINENCE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 15.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR PARKINSON'S DISEASE, BY COUNTRY, 2018 & 2026 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR EPILEPSY, BY COUNTRY, 2018 & 2026 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF NEUROSTIMULATION DEVICES MARKET FOR OTHERS, BY COUNTRY, 2018 & 2026 (%)
FIGURE 18.ABBOTT LABORATORIES: NET SALES, 2016–2018 ($MILLION)
FIGURE 19.ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2018(%)
FIGURE 20.ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2018(%)
FIGURE 21.BOSTON: NET SALES, 2016–2018 ($MILLION)
FIGURE 22.BOSTON: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 23.BOSTON: REVENUE SHARE BY REGION, BY 2018%
FIGURE 24.ELECTROCORE.: NET SALES, 2016–2018 ($MILLION)
FIGURE 25.ELECTROCORE INC.: REVENUE SHARE BY REGION,2018 %
FIGURE 26.MEDTRONIC: NET SALES, 2016–2018 ($MILLION)
FIGURE 27.MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2018 (%)
FIGURE 28.MEDTRONIC PLC: REVENUE SHARE BY REGION, 2018(%)
FIGURE 29.NEVRO CORPORATION.: NET SALES, 2016–2018 ($MILLION)
FIGURE 30.NEVRO CORPORATION.: REVENUE SHARE BY REGION,2018 %
FIGURE 31.NEURONETICS: NET SALES, 2016–2018 ($MILLION)
FIGURE 32.NEURONETICS: REVENUE SHARE BY REGION, 2018(%)
